Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Tang Capital Partners Lp
Relationship:   10% Owner
City:   San Diego
State:   CA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   123,746    

Indirect Shares

   35,438,120      
Direct Value   $21,224    

Indirect Value

   $65,909,068      
Total Shares   35,561,866      
Total Value   $65,930,292      


Ardea Biosciences Inc $0 Heron Therapeutics Inc $18,394 Northstar Neuroscience Inc $0 Molecular Templates, Inc. $2,831 Aradigm Corp $0 Ardea Biosciences Inc $0 Heron Therapeutics Inc $18,394 Northstar Neuroscience Inc $0 Molecular Templates, Inc. $2,831 Aradigm Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    14   
    1    

     Stock price went up :
    3   
    0    
     Stock price went down :
    11   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -4.3%
 -74.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Ardea Biosciences Inc RDEA 10% Owner 2012-02-01 15,089 2012-02-01 3,800,634    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 2018-09-12 6,941 2018-09-12 5,844,562    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 2008-02-15 0 2008-02-19 25,953    Premium*  
            Northstar Neuroscience Inc NSTR 10% Owner 2008-11-18 27,000 2008-11-18 3,706,926    Premium*  
            Neose Technologies Inc NTEC 10% Owner 0 2008-09-30 10,412,306    Premium*  
            Molecular Templates, Inc. MTEM 10% Owner 2008-08-29 4,716 2008-09-29 785,920    Premium*  
            Vanda Pharmaceuticals Inc. VNDA 10% Owner 0 2010-01-14 2,715,852    Premium*  
            Aradigm Corp ARDM 10% Owner 2008-10-21 70,000 2008-10-21 5,877,000    Premium*  
            Penwest Pharmaceuticals Co PPCO 10% Owner 2009-01-09 0 2010-09-20 0    Premium*  
            La Jolla Pharmaceutical Co LJPC 0 2014-07-23 1,699,067    Premium*  
            Cyclacel Pharmaceuticals Inc CYCC 10% Owner 0 2017-02-23 559,900    Premium*  
            Aptevo Therapeutics Inc. APVO Exit Filing 2020-11-04 0 2021-11-23 0    Premium*  
            Jounce Therapeutics Inc JNCE 10% Owner 2023-03-13 0 2023-05-03 10,000    Premium*  
            Tcr2 Therapeutics Inc. TCRR 10% Owner 2023-05-03 0 2023-06-01 0    Premium*  
            Rain Therapeutics Inc. RAIN 10% Owner 2023-05-30 0 2024-01-26 0    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2024-01-26 4 D $0.00 $0 I/I (3,850,513) 0 0 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-12-18 4 S $1.21 $48,560 I/I (40,132) 3,850,513 0 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-12-15 4 S $1.20 $131,322 I/I (109,435) 3,890,645 0 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-12-14 4 S $1.21 $29,531 I/I (24,406) 4,000,080 0 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-10-13 4 B $0.99 $130,315 I/I 131,631 4,024,486 1.5 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-10-12 4 B $0.98 $76,148 I/I 77,702 3,892,855 1.5 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-10-11 4 B $0.97 $72,568 I/I 74,812 3,815,153 1.5 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-06-01 4 B $1.09 $370,534 I/I 333,325 3,740,341 1.5 -
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-06-01 4 D $0.00 $0 I/I (4,394,800) 0 0 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-05-31 4 B $1.08 $179,574 I/I 166,180 3,407,016 1.5 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-05-30 3 IO $0.00 $0 I/I 0 2,652,068 -
RAIN Rain Therapeutics Inc. 10% Owner   –       –       •   2023-05-30 4 B $1.00 $608,655 I/I 588,768 3,240,836 1.5 -
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-25 4 B $1.72 $86,000 I/I 50,000 4,394,800 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-12 4 B $1.95 $12,057 I/I 6,183 4,344,800 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-11 4 B $1.95 $75,592 I/I 38,765 4,338,617 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-10 4 B $1.95 $13,209 I/I 6,774 4,299,852 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-09 4 B $1.95 $39,275 I/I 20,141 4,293,078 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-08 4 B $1.95 $111,292 I/I 57,073 4,272,937 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-05 4 B $1.90 $319,806 I/I 166,823 4,215,864 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-04 4 B $1.86 $193,888 I/I 104,241 4,049,041 1.5 %
TCRR Tcr2 Therapeutics Inc. 10% Owner   –       –       •   2023-05-03 4 B $1.85 $34,249 I/I 18,513 3,944,800 1.5 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-05-03 4 D $1.85 $9,805,161 I/I (5,300,087) 0 0 -
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-05-03 4 A $9,737.70 $97,377,000 I/I 10,000 10,000 0 -
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-14 4 B $1.02 $20,651 I/I 20,286 5,300,087 1.5 %
JNCE Jounce Therapeutics Inc 10% Owner   –       –       •   2023-03-13 3 IO $0.00 $0 I/I 0 5,214,100 %
  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us